4.6 Review

Progress in matrix metalloproteinase research

期刊

MOLECULAR ASPECTS OF MEDICINE
卷 29, 期 5, 页码 290-308

出版社

ELSEVIER
DOI: 10.1016/j.mam.2008.05.002

关键词

Matrixin; Tissue inhibitors of metalloproteinases; Cancer; Cardiovascular disease; Arthritis

资金

  1. Cancer Research UKl
  2. Medical Research Council
  3. European Union
  4. Wellcome Trust
  5. National Institutes of Health [AR40994]
  6. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Matrix metalloproteinases (MMPs) are now acknowledged as key players in the regulation of both cell-cell and cell-extracellular matrix interactions. They are involved in modifying matrix structure, growth factor availability and the function of cell surface signalling systems, with consequent effects on cellular differentiation, proliferation and apoptosis. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury and in the progression of diseases such as arthritis, cancer and cardiovascular disease. Because of their wide spectrum of activities and expression sites, the elucidation of their potential as drug targets in disease or as important features of the repair process will be dependent upon careful analysis of their role in different cellular locations and at different disease stages. Novel approaches to the specific regulation of individual MMPs in different contexts are also being developed. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据